阿片暴露与非暴露新生儿的神经行为特征分析
本研究为多中心前瞻性观察研究,纳入291名足月新生儿(194名阿片暴露,97名未暴露),在生后6周内使用NNNS-II评估神经行为。潜在剖面分析识别出4个独特类别,其中第4类应激迹象最多且几乎均为暴露儿;暴露儿在多数NNNS-II子量表得分与未暴露儿显著不同。除阿片外,产前暴露于苯二氮䓬类、电子烟/烟草及SSRI也与剖面归属相关。
要点
- 阿片暴露新生儿在多数NNNS-II子量表得分与未暴露儿显著不同。
- 潜在剖面分析识别出4类神经行为,第4类应激迹象最多且几乎均为暴露儿。
- 除阿片外,苯二氮䓬类、电子烟/烟草及SSRI暴露也与神经行为剖面归属相关。
核心结论
- 产前暴露于阿片及其他精神活性物质的新生儿具有独特的神经行为模式。
- 这些神经行为差异是否预示未来注意力和行为问题仍需额外随访确定。
研究设计与样本
- Outcomes of Babies with Opioid Exposure研究为多中心前瞻性观察研究。
- 纳入足月阿片暴露新生儿及未暴露对照,由认证检查者在生后6周内施测NNNS-II。
- 采用潜在剖面分析确定神经行为类别,并用线性混合效应模型比较暴露组与未暴露组的NNNS-II得分。
- 共291名新生儿纳入NNNS-II分析,其中暴露194名、未暴露97名。
主要发现
- 潜在剖面分析得到4个独特类别。
- 第4类应激迹象最多,且几乎全部为暴露新生儿。
- 暴露新生儿在大多数NNNS-II子量表上的得分与未暴露新生儿显著不同。
- 除阿片外,剖面归属还与产前暴露于苯二氮䓬类、电子烟/烟草及选择性5-羟色胺再摄取抑制剂相关。
关键数值与推荐
- NNNS-II在生后6周内施测。
- 潜在剖面分析识别出4个神经行为类别。
临床怎么用
- 对产前阿片及精神活性物质暴露新生儿,可在生后6周内用NNNS-II评估神经行为特征。
- 评估时应同时关注苯二氮䓬类、电子烟/烟草及SSRI等产前暴露史。
- 神经行为差异的远期意义尚不明确,需安排随访监测注意力与行为问题。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe distinctive profiles of neurobehavior in opioid-exposed and unexposed neonates. STUDY DESIGN: The Outcomes of Babies with Opioid Exposure study is a multisite, prospective, observational study in neonates born at term with opioid exposure and unexposed controls. As part of the Outcomes of Babies with Opioid Exposure study protocol, certified examiners administered the NeoNatal Neurobehavioral Scales, second edition (NNNS-II) before 6 weeks postnatal age. We used latent profile analysis to determine distinctive classes of neurobehavior and linear mixed effect models to compare NNNS-II scores by exposure status. RESULTS: The study included 291 neonates with NNNS-II, 194 exposed and 97 unexposed. Latent profile analysis resulted in 4 unique classes. Class 4 showed the most signs of stress and included almost exclusively exposed neonates. Scores for exposed neonates were significantly different than unexposed neonates on most NNNS-II subscales. In addition to opioids, associations were found between profile membership and prenatal exposure to benzodiazepines, e-cigarettes/tobacco, and selective serotonin reuptake inhibitors. CONCLUSIONS: Neonates with prenatal exposure to opioids and other psychotropic substances have distinctive patterns of neurobehavior. Additional follow-up is needed to determine if these neurobehavioral differences serve as a marker for future problems with attention and behavior. GOV REGISTRATION: NCT04149509.
引用
- Merhar SL, Yolton K, DeMauro SB, et al. Neurobehavioral Profiles in Opioid-Exposed and Unexposed Neonates. J Pediatr. 2025. PMID: 40057022. doi:10.1016/j.jpeds.2025.114527
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。